Tom Loosli

[Tom Loosli @LoosliTom]

@Esteban09090 @eggersnsf @MedArXiv @iedeaglobal @rjlessells @RogerKouyos @jonathanasterne @HGunthard @Epidemics_bees @annettesohnBKK @epi_dude @ProfMattFox @kerinalthoff Thanks @Esteban09090, good point! Our analysis focuses on DTG resistance in people on DTG regimens, hence results do not contradict NADIA, which considers a different outcome: NRTI resistance may not affect failure rates, but increases the risk of resistance given failure occurs.